LV Mass Independently Predicts Mortality and Need for Future Revascularization in Patients Undergoing Diagnostic Coronary Angiography

JACC: Cardiovascular Imaging

Volumn 11, Issue 3, 2018, Pages 423-433

  Abdi Ali, Ahmed ^a   Miller, Robert J H ^a   Southern, Danielle ^b   Zhang, Mei ^b   Mikami, Yoko ^a   Knudtson, Merril ^a,b   Heydari, Bobak ^a   Howarth, Andrew G ^a   Lydell, Carmen P ^a   James, Mathew T ^a,b   Wilton, Stephen B ^a,b   White, James A ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

coronary disease; left ventricular mass; magnetic resonance imaging; mortality

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ALL CAUSE MORTALITY; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; COMORBIDITY; CONTROLLED STUDY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ADVERSE EVENT; CINE MAGNETIC RESONANCE IMAGING; DIAGNOSTIC IMAGING; DISEASE EXACERBATION; HEART VENTRICLE REMODELING; MORTALITY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; REGISTER; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TIME FACTOR;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PREDICTIVE VALUE OF TESTS; PROGRESSION-FREE SURVIVAL; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 85025434600     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2017.04.012     Document Type: Article

References (33)

1. Gardin, J.M., Arnold, A., Gottdiener, J.S., et al. Left ventricular mass in the elderly: the Cardiovascular Health Study. Hypertension 29 (1997), 1095–1103.
2. Koren, M.J., Devereux, R.B., Casale, P.N., Savage, D.D., Laragh, J.H., Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 114 (1991), 345–352.
3. Krumholz, H.M., Larson, M., Levy, D., Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol 25 (1995), 879–884.
4. Bluemke, D.A., Kronmal, R.A., Lima, J.A., et al. The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) Study. J Am Coll Cardiol 52 (2008), 2148–2155.
5. Haider, A.W., Larson, M.G., Benjamin, E.J., Levy, D., Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol 32 (1998), 1454–1459.
6. Levy, D., Garrison, R.J., Savage, D.D., Kannel, W.B., Castelli, W.P., Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322 (1990), 1561–1566.
7. Turakhia, M.P., Schiller, N.B., Whooley, M.A., Prognostic significance of increased left ventricular mass index to mortality and sudden death in patients with stable coronary heart disease (from the Heart and Soul Study). Am J Cardiol 102 (2008), 1131–1135.
8. Bottini, P.B., Carr, A.A., Prisant, L.M., Flickinger, F.W., Allison, J.D., Gottdiener, J.S., Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient. Am J Hypertens 8 (1995), 221–228.
9. Seo, H.Y., Lee, S.P., Park, J.B., et al. Discrepancies in left ventricular mass calculation based on echocardiography and cardiovascular magnetic resonance measurements in patients with left ventricular hypertrophy. J Am Soc Echocardiogr 28 (2015), 1194–1203.
10. Marwick, T.H., Gillebert, T.C., Aurigemma, G., et al. Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE). J Am Soc Echocardiogr 28 (2015), 727–754.
11. Chuang, M.L., Beaudin, R.A., Riley, M.F., et al. Three-dimensional echocardiographic measurement of left ventricular mass: comparison with magnetic resonance imaging and two-dimensional echocardiographic determinations in man. Int J Card Imaging 16 (2000), 347–357.
12. Greenwood, J.P., Herzog, B.A., Brown, J.M., et al. Prognostic value of cardiovascular magnetic resonance and single-photon emission computed tomography in suspected coronary heart disease: long-term follow-up of a prospective, diagnostic accuracy cohort study. Ann Intern Med, 2016 May 10 [E-pub ahead of print].
13. Scott, P.A., Rosengarten, J.A., Curzen, N.P., Morgan, J.M., Late gadolinium enhancement cardiac magnetic resonance imaging for the prediction of ventricular tachyarrhythmic events: a meta-analysis. Eur J Heart Fail 15 (2013), 1019–1027.
14. Chirinos, J.A., Segers, P., De Buyzere, M.L., et al. Left ventricular mass: allometric scaling, normative values, effect of obesity, and prognostic performance. Hypertension 56 (2010), 91–98.
15. Krittayaphong, R., Boonyasirinant, T., Saiviroonporn, P., et al. Prognostic significance of left ventricular mass by magnetic resonance imaging study in patients with known or suspected coronary artery disease. J Hypertens 27 (2009), 2249–2256.
16. Ghali, W.A., Knudtson, M.L., Overview of the Alberta provincial project for outcome assessment in coronary heart disease (on behalf of the APPROACH investigators). Can J Cardiol 16 (2000), 1225–1230.
17. Hudsmith, L.E., Petersen, S.E., Francis, J.M., Robson, M.D., Neubauer, S., Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J Cardiovasc Magn Reson 7 (2005), 775–782.
18. Kawel-Boehm, N., Maceira, A., Valsangiacomo-Buechel, E.R., et al. Normal values for cardiovascular magnetic resonance in adults and children. J Cardiovasc Magn Reson, 17, 2015, 29.
19. Chuang, M.L., Gona, P., Hautvast, G.L., et al. CMR reference values for left ventricular volumes, mass, and ejection fraction using computer-aided analysis: the Framingham Heart Study. J Magn Reson Imaging 39 (2014), 895–900.
20. Califf, R.M., Phillips, H.R. 3rd, Hindman, M.C., et al. Prognostic value of a coronary artery jeopardy score. J Am Coll Cardiol 5 (1985), 1055–1063.
21. Steyerberg, E.W., Eijkemans, M.J., Harrell, F.E. Jr., Habbema, J.D., Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Stat Med 19 (2000), 1059–1079.
22. Wang, T.J., Evans, J.C., Benjamin, E.J., Levy, D., LeRoy, E.C., Vasan, R.S., Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation 108 (2003), 977–982.
23. Levy, D., Labib, S.B., Anderson, K.M., Christiansen, J.C., Kannel, W.B., Castelli, W.P., Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation 81 (1990), 815–820.
24. Chiang, B.N., Perlman, L.V., Fulton, M., Ostrander, L.D. Jr., Epstein, F.H., Predisposing factors in sudden cardiac death in Tecumseh, Michigan. A prospective study. Circulation 41 (1970), 31–37.
25. Kannel, W.B., Doyle, J.T., McNamara, P.M., Quickenton, P., Gordon, T., Precursors of sudden coronary death. Factors related to the incidence of sudden death. Circulation 51 (1975), 606–613.
26. Quiñones, M.A., Greenberg, B.H., Kopelen, H.A., et al. Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. Studies of left ventricular dysfunction. J Am Coll Cardiol 35 (2000), 1237–1244.
27. Devereux, R.B., Reichek, N., Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55 (1977), 613–618.
28. Park, S.H., Shub, C., Nobrega, T.P., et al. Two-dimensional echocardiographic calculation of left ventricular mass as recommended by the American Society of Echocardiography: correlation with autopsy and M-mode echocardiography. J Am Soc Echocardiogr 9 (1996), 119–128.
29. Farber, N.J., Reddy, S.T., Doyle, M., et al. Ex vivo cardiovascular magnetic resonance measurements of right and left ventricular mass compared with direct mass measurement in excised hearts after transplantation: a first human SSFP comparison. J Cardiovasc Magn Reson, 16, 2014, 74.
30. Janik, M., Cham, M.D., Ross, M., et al. Effects of papillary muscles and trabeculae on left ventricular quantification: increased impact of methodological variability in patients with left ventricular hypertrophy. J Hypertens 26 (2008), 1677–1685.
31. Kozor, R., Callaghan, F., Tchan, M., et al. A disproportionate contribution of papillary muscles and trabeculations to total left ventricular mass makes choice of cardiovascular magnetic resonance analysis technique critical in Fabry disease. J Cardiovasc Magn Reson, 17, 2015, 22.
32. Dahabreh, I.J., Kent, D.M., Index event bias as an explanation for the paradoxes of recurrence risk research. JAMA 305 (2011), 822–823.
33. Barbash, G.I., Reiner, J., White, H.D., et al. Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the “smoker's paradox” from the GUSTO-I trial, with angiographic insights. J Am Coll Cardiol 26 (1995), 1222–1229.